Analyst Rami Katkhuda of LifeSci Capital maintained a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report), retaining the price ...

Praxis Precision Medicines Inc (PRAX) reports robust financial health and significant progress in its clinical pipeline, ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Presented interim data from the ongoing Phase 1 dose escalation study of PRT3789, its first-in-class IV SMARCA2 degrader, demonstrating clinical ...

Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...

Netflix is a streaming television behemoth with a dominant market share and a long growth runway around the world ... robotic ...

DOYLESTOWN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through ...

Manufactured by Edge Autonomy, the VXE30 Stalker is the program-of-record platform for the U.S. Navy and Marine Corps Small Tactical Unmanned Aircraft Systems (PMA-263) long-range, long-endurance ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended Se ...

As the U.S. stock market takes a breather after a significant post-election rally, investors are assessing their portfolios amid heightened optimism and fluctuating indices. In this context, penny ...

While one answer is to work harder and learn through repeated trial and error, that’s not a guarantee, and it means running ...

We continue to be well capitalized with an anticipated cash runway into the first half of 2027 and are ... We are a clinical-stage precision oncology company singularly focused on discovering, ...